Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA

BACKGROUND: The application of precision medicine in oncology requires in-depth characterisation of a patient's tumours and the dynamics of their responses to treatment. PATIENTS AND METHODS: We used next-generation sequencing of circulating cell-free DNA (cfDNA) to monitor the response of a KI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremel, G., Lee, R. J., Girotti, M. R., Mandal, A. K., Valpione, S., Garner, G., Ayub, M., Wood, S., Rothwell, D. G., Fusi, A., Wallace, A., Brady, G., Dive, C., Dhomen, N., Lorigan, P., Marais, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035787/
https://www.ncbi.nlm.nih.gov/pubmed/27502704
http://dx.doi.org/10.1093/annonc/mdw278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035787/
https://www.ncbi.nlm.nih.gov/pubmed/27502704
http://dx.doi.org/10.1093/annonc/mdw278

Ejemplares similares